Literature DB >> 3358708

Magnetic resonance imaging in familial paroxysmal ataxia.

A Vighetto1, J C Froment, M Trillet, G Aimard.   

Abstract

A magnetic resonance imaging study was performed in three symptomatic members of two families with a diagnosis of acetazolamide-responsive familial paroxysmal ataxia. A selective atrophy of the cerebellar vermis, mostly of the anterior part, was demonstrated in the three cases. The first ample documentation of a neuroanatomical abnormality in this condition was achieved in this study.

Entities:  

Mesh:

Year:  1988        PMID: 3358708     DOI: 10.1001/archneur.1988.00520290083018

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  10 in total

Review 1.  Neuronal P/Q-type calcium channel dysfunction in inherited disorders of the CNS.

Authors:  Sanjeev Rajakulendran; Diego Kaski; Michael G Hanna
Journal:  Nat Rev Neurol       Date:  2012-01-17       Impact factor: 42.937

2.  Familial paroxysmal ataxia: report of a family.

Authors:  C H Hawkes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

3.  Cranial MRI in ataxia-telangiectasia.

Authors:  F Sardanelli; R C Parodi; C Ottonello; P Renzetti; S Saitta; E Lignana; G L Mancardi
Journal:  Neuroradiology       Date:  1995-01       Impact factor: 2.804

Review 4.  Episodic ataxia type 2.

Authors:  Michael Strupp; Andreas Zwergal; Thomas Brandt
Journal:  Neurotherapeutics       Date:  2007-04       Impact factor: 7.620

5.  Familial periodic cerebellar ataxia without myokymia maps to a 19-cM region on 19p13.

Authors:  B T Teh; P Silburn; K Lindblad; R Betz; R Boyle; M Schalling; C Larsson
Journal:  Am J Hum Genet       Date:  1995-06       Impact factor: 11.025

6.  Acetazolamide: A New Treatment for Visual Vertigo.

Authors:  Ilya M Sluch; Michael S Elliott; Justin Dvorak; Kai Ding; Bradley K Farris
Journal:  Neuroophthalmology       Date:  2017-08-02

Review 7.  'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 2: Anti-PKC-gamma, anti-GluR-delta2, anti-Ca/ARHGAP26 and anti-VGCC.

Authors:  S Jarius; B Wildemann
Journal:  J Neuroinflammation       Date:  2015-09-17       Impact factor: 8.322

Review 8.  Facts of Vertigo in Adolescents: Controversies and Challenges - A Narrative Review.

Authors:  Melissa Castillo-Bustamante; Mariana Barona Cabrera; Sara Suárez Angulo; Mariana García Campuzano; Alejandro García; Jorge Madrigal
Journal:  Cureus       Date:  2022-08-23

Review 9.  Brain sites of movement disorder: genetic and environmental agents in neurodevelopmental perturbations.

Authors:  T Palomo; R J Beninger; R M Kostrzewa; T Archer
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.978

Review 10.  Episodic ataxia type 1: a neuronal potassium channelopathy.

Authors:  Sanjeev Rajakulendran; Stephanie Schorge; Dimitri M Kullmann; Michael G Hanna
Journal:  Neurotherapeutics       Date:  2007-04       Impact factor: 7.620

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.